Citation: Rt. Means et al., SERUM-SOLUBLE TRANSFERRIN RECEPTOR IN THE DIAGNOSIS OR IRON-DEFICIENCY IN PATIENTS WITH MULTIPLE MEDICAL PROBLEMS, Journal of investigative medicine, 46(3), 1998, pp. 213-213
Citation: M. North et al., EFFECTS OF CERAMIDE ON HUMAN ERYTHROID COLONY FORMATION - INVOLVEMENTIN THE INHIBITION INDUCED BY GAMMA-INTERFERON, Experimental hematology, 26(8), 1998, pp. 462-462
Citation: Sw. Mckenzie et Rt. Means, EXTREME HYPERFERRITINEMIA IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS IS NOT A HIGHLY SPECIFIC MARKER FOR DISSEMINATED HISTOPLASMOSIS, Clinical infectious diseases, 24(3), 1997, pp. 519-520
Authors:
NORTH M
DALLALIO G
DONATH AS
MELINK R
MEANS RT
Citation: M. North et al., SERUM TRANSFERRIN RECEPTOR LEVELS IN PATIENTS UNDERGOING EVALUATION OF IRON STORES - CORRELATION WITH OTHER PARAMETERS AND OBSERVED VERSUS PREDICTED RESULTS, Clinical and laboratory haematology, 19(2), 1997, pp. 93-97
Citation: Rt. Means et al., EFFECTS OF CERAMIDE ON HUMAN ERYTHROID COLONY FORMATION - INVOLVEMENTIN THE INHIBITION INDUCED BY GAMMA-INTERFERON, Blood, 90(10), 1997, pp. 3452-3452
Citation: Rt. Means et al., POSITIVE EFFECT OF MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA ON HUMAN ERYTHROID COLONY FORMATION IN-VITRO, Blood, 90(10), 1997, pp. 3453-3453
Authors:
DAI W
PAN HQ
OUYANG B
GREENBERG JM
MEANS RT
LI B
CARDIE J
Citation: W. Dai et al., EXPRESSION OF RECEPTOR PROTEIN-TYROSINE KINASE TIF IS REGULATED DURING LEUKEMIA-CELL DIFFERENTIATION, Leukemia, 10(6), 1996, pp. 978-983
Citation: G. Dallalio et al., INHIBITION OF MARROW CFU-E COLONY FORMATION FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS BY BETA-INTERFERON AND GAMMA-INTERFERON, American journal of hematology, 53(2), 1996, pp. 118-120
Citation: Rt. Means et Sb. Krantz, INHIBITION OF HUMAN ERYTHROID COLONY-FORMING-UNITS BY INTERFERON-ALPHA AND INTERFERON-BETA - DIFFERING MECHANISMS DESPITE SHARED RECEPTOR, Experimental hematology, 24(2), 1996, pp. 204-208
Authors:
MEANS RT
MENDENHALL CL
WORDEN BD
MORITZ TE
CHEDID A
Citation: Rt. Means et al., ERYTHROPOIETIN AND CYTOKINE LEVELS IN THE ANEMIA OF SEVERE ALCOHOLIC LIVER-DISEASE, Alcoholism, clinical and experimental research, 20(2), 1996, pp. 355-358
Citation: Rt. Means et al., BONE-MARROW, BUT NOT SERUM, CHEMOKINE LEVELS DIFFER BETWEEN HEALTHY-INDIVIDUALS AND PATIENTS WITH ACQUIRED IMMUNODEFICIENCY, Blood, 88(10), 1996, pp. 1348-1348
Citation: Rt. Means et al., CORRELATION OF SERUM TRANSFERRIN RECEPTOR LEVELS WITH OTHER PARAMETERS IN PATIENTS UNDERGOING EVALUATION OF IRON STATUS - OBSERVED VS PREDICTED RESULTS, Blood, 88(10), 1996, pp. 1942-1942
Citation: Rt. Means, ELEVATED SERUM FERRITIN LEVELS - ASSOCIATED DISEASES AND CLINICAL-SIGNIFICANCE - REPLY, The American journal of medicine, 101(1), 1996, pp. 122-122
Citation: Mh. Lee et Rt. Means, EXTREMELY ELEVATED SERUM FERRITIN LEVELS IN A UNIVERSITY HOSPITAL - ASSOCIATED DISEASES AND CLINICAL-SIGNIFICANCE, The American journal of medicine, 98(6), 1995, pp. 566-571
Citation: Rt. Means, CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN THE ANEMIA OF CHRONIC DISEASE, Hematology/oncology clinics of North America, 8(5), 1994, pp. 933
Citation: Rt. Means, FAILURE OF ERYTHROPOIETIN TO CORRECT INHIBITION OF ERYTHROID COLONY FORMATION BY INTERFERON-BETA IN-VITRO, Clinical research, 42(3), 1994, pp. 10000405-10000405